Growth Metrics

Neogenomics (NEO) Short term Debt (2016 - 2020)

Historic Short term Debt for Neogenomics (NEO) over the last 12 years, with Q1 2020 value amounting to $5.0 million.

  • Neogenomics' Short term Debt fell 3649.18% to $5.0 million in Q1 2020 from the same period last year, while for Mar 2020 it was $5.0 million, marking a year-over-year decrease of 3649.18%. This contributed to the annual value of $5.0 million for FY2019, which is 3649.18% down from last year.
  • Latest data reveals that Neogenomics reported Short term Debt of $5.0 million as of Q1 2020, which was down 3649.18% from $5.0 million recorded in Q4 2019.
  • In the past 5 years, Neogenomics' Short term Debt ranged from a high of $8.8 million in Q1 2017 and a low of $596000.0 during Q1 2016
  • Moreover, its 5-year median value for Short term Debt was $5.0 million (2019), whereas its average is $4.8 million.
  • Per our database at Business Quant, Neogenomics' Short term Debt crashed by 5771.79% in 2016 and then soared by 138221.48% in 2017.
  • Neogenomics' Short term Debt (Quarter) stood at $3.8 million in 2016, then changed by 0.0% to $3.8 million in 2017, then surged by 109.95% to $7.9 million in 2018, then plummeted by 36.49% to $5.0 million in 2019, then changed by 0.0% to $5.0 million in 2020.
  • Its Short term Debt stands at $5.0 million for Q1 2020, versus $5.0 million for Q4 2019 and $6.2 million for Q3 2019.